Ipsen and Galderma become exclusive partners for development and marketing of neurotoxins in the US, Canada, Brazil and Europe1

Ipsen and Galderma to expand their current distribution agreement for Dysport®/Azzalure® in aesthetic and dermatology indications to the US and Canada Ipsen and Galderma to collaborate on development and commercialization of new neurotoxins, inc... Biopharmaceuticals, Dermatology, DistributionIpsen, Galderma, Dysport, Azzalure

http://salesandmarketingnetwork.com/news_release.php?ID=2039017

Source: HSMN NewsFeed - July 11, 2014 Category: Pharmaceuticals Source Type: news